Meeting to be held in New York on October 23-27 hosted by Piper Sandler.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CMPX:
- Promising Outlook for Compass Therapeutics: Buy Rating Backed by COMPANION-002 Trial Success and Market Potential
- Buy Rating for Compass Therapeutics Driven by Promising Clinical Trial Data and Strategic Enrollment
- Compass Therapeutics initiated with an Outperform at LifeSci Capital
- Positive Outlook for Compass Therapeutics: Buy Rating Backed by Promising Pipeline and Market Potential
- Compass Therapeutics management to meet with Piper Sandler